Compare ACLX & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACLX | RYN |
|---|---|---|
| Founded | 2015 | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.3B |
| IPO Year | 2022 | N/A |
| Metric | ACLX | RYN |
|---|---|---|
| Price | $66.63 | $23.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | ★ $113.75 | $27.00 |
| AVG Volume (30 Days) | 890.8K | ★ 1.8M |
| Earning Date | 02-26-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 12.46% |
| EPS Growth | N/A | ★ 373.89 |
| EPS | N/A | ★ 5.07 |
| Revenue | $35,898,000.00 | ★ $1,293,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $293.08 | N/A |
| P/E Ratio | ★ N/A | $4.58 |
| Revenue Growth | N/A | ★ 60.70 |
| 52 Week Low | $47.86 | $21.06 |
| 52 Week High | $94.07 | $28.31 |
| Indicator | ACLX | RYN |
|---|---|---|
| Relative Strength Index (RSI) | 47.88 | 60.02 |
| Support Level | $63.33 | $21.45 |
| Resistance Level | $66.83 | $23.60 |
| Average True Range (ATR) | 2.27 | 0.50 |
| MACD | 0.85 | 0.19 |
| Stochastic Oscillator | 93.96 | 74.78 |
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.